Our study assessed the ability of existing influenza antivirals to treat severe A(H5N1) influenza in a mouse model. Results were dependent on drug, dosage and infection route but highlighted the need to explore further options for treatment.
Access through your institution
Buy or subscribe
This is a preview of subscription content, access via your institution
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Learn more
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Learn more
Buy this article
Purchase on SpringerLink
Instant access to full article PDF
Buy now
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Log in
Learn about institutional subscriptions
Read our FAQs
Contact customer support
Fig. 1: Effects of influenza antivirals on mice exposed to A(H5N1)-contaminated dairy cow milk.
References
Peacock, T. P. et al. The global H5N1 influenza panzootic in mammals. Nature 637, 304–313 (2025). A review article describing ecological and molecular factors driving the current expansion of influenza A(H5N1).
ArticleCASPubMedGoogle Scholar
Mostafa, A. et al. Avian influenza A (H5N1) virus in dairy cattle: origin, evolution, and cross-species transmission. mBio 15, e02542-24 (2024). A review article describing the emergence and initial characterization of influenza A(H5N1) in dairy cattle.
ArticlePubMedPubMed CentralGoogle Scholar
H5 bird flu: current situation. CDChttps://www.cdc.gov/bird-flu/situation-summary/index.html (2025). A US government website tracking current human A(H5N1) infections following animal exposure.
Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. CDChttps://www.cdc.gov/bird-flu/hcp/novel-av-treatment-guidance/index.html (2024). The US government interim guidelines on antiviral use for severe or zoonotic influenza.
Download references
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Jones, J. C. et al. Baloxavir improves disease outcomes in mice after intranasal or ocular infection with Influenza A virus H5N1-contaminated cow’s milk. Nat. Microbiol. https://doi.org/10.1038/s41564-025-01961-5 (2025).
Rights and permissions
Reprints and permissions
About this article
Check for updates. Verify currency and authenticity via CrossMark
Cite this article
The challenges of treating severe A(H5N1) influenza. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-01974-0
Download citation
Published:02 April 2025
DOI:https://doi.org/10.1038/s41564-025-01974-0
Share this article
Anyone you share the following link with will be able to read this content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative